Rona Therapeutics, a biotechnology company pioneering innovative RNA-targeted therapies, announced that the Investigational New Drug (IND) application for RN1871, a small interfering RNA (siRNA) drug ...

CHICAGO, IL—An investigational agent given by subcutaneous injection can drastically reduce levels of lipoprotein (a), with ...

Itoophiyaa fi waraana- Gaa'ila Hiikkaa barbaadan jechuun tibbana kitaaba isaanii kan maxxansiisan Let Jeneraal Yohaannis ...

China NMPA approves Rona Therapeutics’ IND application for RN1871, a novel AGT-targeting siRNA drug for hypertension: Shanghai, China Tuesday, April 22, 2025, 18:00 Hrs [IST] Ro ...

Silexion Therapeutics (SLXN) announced a strategic collaboration with Catalent (CTLT). Under the agreement, Catalent will conduct formulation ...

Background Fibrolamellar carcinoma (FLC), a rare and fatal liver cancer lacking effective drug therapy, is driven by the DNAJ-PKAc fusion oncoprotein. However, the underlying mechanism of DNAJ-PKAc’s ...

Akka Nasan ibsetti waggaa wagggaan wantoonni caccabaa dhagaa fakkaatan hawaa keessaa gara pilaaneetii keenya Dacheetti ni ...

A biochemistry postgrad with a passion for poetry and science, Prayagraj's Shakti Dubey credits her family, teachers and her ...

By leveraging siRNA technology to treat disease fundamentally, RN1871 achieves sustained efficacy with less dosing frequency. We look forward to bringing this innovative therapy to hypertension ...

Novotech, a globally recognized full-service clinical research organization (CRO) and scientific advisory company, has released its newest preclinical report exploring the evolving landscape of ...